Paul Ginsburg

Revising payment to Medicare Advantage plans to reflect the rapid growth in enrollment

11:00 AM - 12:00 PM EDT

Wall Street Comes to Washington health care roundtable

2:00 PM - 3:30 PM EDT

Nurse with Elderly Patient

The debate on overpayment in Medicare Advantage: Pulling it together

Paul B. Ginsburg and Steven M. Lieberman

Friday, February 25, 2022

Private equity investment as a divining rod for market failure: Policy responses to harmful physician practice acquisitions

Erin C. Fuse Brown, Loren Adler, Erin Duffy, Paul B. Ginsburg, Mark Hall, and Samuel Valdez

Tuesday, October 5, 2021

A framework for categorizing and analyzing prescription drug pricing reform options

Rachel Sachs, Loren Adler, and Paul B. Ginsburg

Tuesday, August 31, 2021

shutterstock_794226628 (1).jpg

Government regulated or negotiated drug prices: Key design considerations

Paul B. Ginsburg and Steven M. Lieberman

Monday, August 30, 2021

Drug rebates in Medicare Part D

1:30 PM - 2:45 PM EDT

Wall Street Comes to Washington health care roundtable

2:00 PM - 3:45 PM EDT

MRI

Medicare advanced imaging payment: Dysfunctional policy making

Bruce Steinwald, Paul B. Ginsburg, Caitlin Brandt, and Sobin Lee

Wednesday, March 31, 2021

Drug administered

Medicare payment for physician-administered (Part B) drugs

Paul B. Ginsburg and Steven M. Lieberman

Wednesday, February 10, 2021